Classification of Medicines
Pursuant to section 106(1) of the Medicines Act 1981, I, Chris James, Group Manager, Medsafe, Ministry of Health, acting under delegated authority, hereby declare the following:
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
Unless specific reference is made otherwise, every reference to a medicine applies:
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
In accordance with section 106(2) of the Act, to the extent that any part of this notice is inconsistent with any provisions of any regulations made under section 105(1)(j) of the Act, the provisions in those regulations cease to have effect while this notice remains in force.
Respiratory syncytial virus vaccine; Prescription except when administered for the prevention of lower respiratory tract disease caused by respiratory syncytial virus RSV-A and RSV-B subtypes to a person 60 years of age or older by registered pharmacists, who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by Te Whatu Ora) and who complies with the immunisation standards of Health NZ | Te Whatu Ora.
Dated this 18th day of December 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health.